Gufic Biosciences: Notice to Equity Shareholders for IEPF Share Transfer

Gufic Biosciences Limited has issued a notice to its equity shareholders regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Authority. This action is being taken in accordance with Section 124(6) of the Companies Act, 2013, and Rule 6 of the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.

The shares being transferred are those in respect of which the dividend declared for the Financial Year 2018-19 has remained unclaimed or unpaid for seven consecutive years or more. The company has previously communicated with these shareholders individually, requesting them to claim their unpaid dividends before the transfer to IEPF.

Shareholders who have valid claims with all requisite documents submitted by October 30, 2026, will be processed according to applicable laws. If no valid claim is made by this date, the shares associated with unpaid or unclaimed dividends will be transferred to the IEPF Authority's demat account without further notice. The company has also uploaded a statement detailing these shareholders and shares on its website.

For shareholders holding shares in physical form, duplicate share certificates will be issued for dematerialization and transfer to IEPF, after which the original certificates will be automatically cancelled. For shares held in demat form, the company will inform the depository for the transfer. Shareholders can claim their unclaimed dividends from the company or its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited, on or before October 30, 2026. Claims made after this date will need to be pursued directly with the IEPF Authority using Form IEPF-5.